Medicus Pharma (MDCX) is scheduled to report Q4 earnings on March 27, 2026. Analysts estimate EPS of $-0.34 and quarterly revenue of N/A.

In the most recent quarter (Q3), Medicus Pharma reported EPS of $-1.12, missing estimates of $-0.38 by 1.95%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Medicus Pharma has missed EPS estimates in 2 consecutive quarters.

Over the last 2 quarters, Medicus Pharma has averaged an EPS surprise of 1.02% and a revenue surprise of 0.00%.